An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and increased skeletal muscle regeneration.

Inflammation Muscle biopsies Muscular regeneration Myopathology

Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
14 Jan 2024
Historique:
received: 25 10 2023
revised: 26 12 2023
accepted: 08 01 2024
medline: 2 2 2024
pubmed: 2 2 2024
entrez: 2 2 2024
Statut: aheadofprint

Résumé

The aim of this study was to identify key routinely used myopathologic biomarkers of FSHD1. Needle muscle biopsies were taken in 34 affected muscles (m. quadriceps femoris (QF), n = 20, m. tibialis anterior (TA), n = 13, m. biceps brachii, n = 1) from 22 patients (age, 53.5 (10) years; M = 12, F = 10). Eleven patients had more than one biopsy (2xQF, n = 1; QF+TA, n = 9; 2xQF+TA, n = 1). Histochemistry, immunoperoxidase, and immunofluorescence stainings were performed and compared to age and muscle type matched muscle specimens of 11 healthy controls. Myopathologic features observed in our FSHD1 cohort were internalized nuclei, type 1 fibre hypertrophy and NADH central clearances/cores. We observed a prominent inflammatory response with MAC deposits, MHC I expression, and muscle regeneration that correlated with the inflammatory score. Our up-to-date characterization of FSHD1 points towards MHC I, MAC, and embryonic Myosin Heavy Chain/muscle regeneration as useful myopathologic readouts of FSHD1.

Identifiants

pubmed: 38306719
pii: S0960-8966(24)00002-6
doi: 10.1016/j.nmd.2024.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-15

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Lisanne Hubregtse (L)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France; The Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.

Karlijn Bouman (K)

The Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.

Chéryane Lama (C)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France.

Saskia Lassche (S)

The Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.

Nicolas de Graaf (N)

The Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.

Valentina Taglietti (V)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France.

Benno Küsters (B)

Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands.

Baptiste Periou (B)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France.

Frédéric Relaix (F)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France.

Baziel van Engelen (B)

Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands.

François-Jerôme Authier (FJ)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France; Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital, France.

Nicol C Voermans (NC)

The Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, the Netherlands.

Edoardo Malfatti (E)

Université Paris Est Créteil, INSERM, U955, IMRB, Créteil F-94010, France; Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital, France. Electronic address: edoardo.malfatti@aphp.fr.

Classifications MeSH